Early research (Phase 1)Looking for participantsNCT06994143
What this trial is testing
CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid Arthritis
Who this might be right for
Rheumatoid Arthritis (RA
Cullinan Therapeutics Inc. 37